NCT01128569View on ClinicalTrials.gov

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Asthma
Interventions
DRUG

Fluticasone Furoate

FF

DRUG

FF/Vilanterol (VI; GW642444M)

FF/VI

DRUG

Placebo

Placebo Inhaler

Trial Locations (4)

6021

GSK Investigational Site, Wellington

14050

GSK Investigational Site, Berlin

NW10 7EW

GSK Investigational Site, London

M23 9QZ

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01128569 - Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response | Biotech Hunter | Biotech Hunter